Mytrex Health Technologies (ROCO:4431) Marketable Securities: NT$71 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:4431 Mytrex Health Technologies Inc ROCO:4431
68 GF Score
Price NT$18.75
GF Value NT$28.48
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is Mytrex Health Technologies Marketable Securities?

Mytrex Health Technologies ROCO:4431 +1.90% 68 Marketable Securities is NT$71 Mil as of Jun. 2026. GuruFocus rates ROCO:4431 with a GF Score™ of 68/100 and a GF Value™ of NT$28.48 (Significantly Undervalued). The stock has 5 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Mytrex Health Technologies's Marketable Securities for the quarter that ended in Jun. 2026 was NT$71 Mil.

Mytrex Health Technologies's annual Marketable Securities declined from Dec. 2023 (NT$22 Mil) to Dec. 2024 (NT$3 Mil) but then increased from Dec. 2024 (NT$3 Mil) to Dec. 2025 (NT$121 Mil).

Mytrex Health Technologies  (ROCO:4431) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Mytrex Health Technologies Marketable Securities Related Terms

Mytrex Health Technologies Marketable Securities Historical Data

* Premium members only.

The historical data trend for Mytrex Health Technologies's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mytrex Health Technologies Marketable Securities Chart

Mytrex Health Technologies Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 22.09 2.50 121.00

Mytrex Health Technologies Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 44.50 2.50 105.51 121.00 70.68
ROCO:4431
68GF Score
Mytrex Health Technologies Inc ROCO:4431
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Mytrex Health Technologies Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of NT$71 Mil mean?
Mytrex Health Technologies (ROCO:4431) has a Marketable Securities of NT$71 Mil as of Jun. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Mytrex Health Technologies and its competitors.
Is Mytrex Health Technologies' Marketable Securities too high?
Mytrex Health Technologies' current Marketable Securities is NT$71 Mil. Overall, Mytrex Health Technologies has a GF Score™ of 68/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Mytrex Health Technologies' Marketable Securities compare to GEV and ETN?
Mytrex Health Technologies' Marketable Securities of NT$71 Mil can be compared against companies in the Industrial Products industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for an Industrial Products company?
A good Marketable Securities depends on the Industrial Products industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Mytrex Health Technologies and its competitors. Mytrex Health Technologies's current Marketable Securities is NT$71 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mytrex Health Technologies stock overvalued right now?
Based on GuruFocus' analysis, Mytrex Health Technologies (ROCO:4431) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$28.48, compared to a current price of NT$18.75 — trading 34.2% below its estimated fair value. The current Marketable Securities is NT$71 Mil. Mytrex Health Technologies' overall GF Score™ is 68/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Mytrex Health Technologies (ROCO:4431), the current Marketable Securities is NT$71 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Mytrex Health Technologies (ROCO:4431) Overvalued in 2026?

Based on GuruFocus' analysis, Mytrex Health Technologies stock appears to be undervalued. The current stock price of NT$18.75 is trading 34.2% below its estimated GF Value™ of NT$28.48. GuruFocus considers Mytrex Health Technologies to be Significantly Undervalued.

Key valuation signals for ROCO:4431:

  • Marketable Securities: NT$71 Mil
  • GF Value™: NT$28.48 vs. price of NT$18.75 (34.2% below fair value)
  • GF Score™: 68/100 with 5 warning signs

No single metric tells the full story. See the ROCO:4431 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Mytrex Health Technologies Business Description

Address No. 545, Section 2, Hezhen North Road, Zhongli District, Taoyuan, TWN, 32060
Mytrex Health Technologies Inc is a Taiwan-based company engaged in the manufacturing of non-woven materials and special medical supplies. It is engaged in the development and production of melt-blown products for the protection of the environment and human health. The company offers products ranging from medical to industrial filtration materials such as various types of filtration media, lab coats or outfits, cabin filtration, vacuum cleaner filter bags, and special medical supplies. Its product categories include meltdown, mammoth bedding, and specialized medical supplies like balloon catheters and coronary stents.
68GF Score

Get the complete analysis for ROCO:4431

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$18.75
Price
NT$28.48
GF Value